eng URI http://hdl.handle.net/10795/2901 βιοχημεία καρκίνος πρόληψη των ασθενειών Apoptosis is a highly orchestrated, genetically regulated form of cell death, the impairment of which is crucial in breast cancer (BC) development and progression. BCL2L12, a member of the BCL2 family of apoptosis-related genes, has been studied in various malignancies, revealing its potential role as a tumor biomarker. It has been recently found that BCL2L12 is subjected to alternative splicing, resulting in the generation of 13 alternatively spliced variants. The aim of this study was the quantification of BCL2L12 splice variants 1 and 2 (v.1 and v.2) expression at the mRNA level and the assessment of their biomarker potential in BC. 2 pp. LOMv1.0 creator LOMv1.0 publisher LOMv1.0 Scientific Coordinator LOMv1.0 Project Final Beneficiary LOMv1.0 Project Executing Organisation 2014 Digital Library of the Operational Programme "Education and Lifelong Learning" abstract types Text Apoptosis Breast cancer 347856 application/pdf http://repository.edulll.gr/edulll/bitstream/10795/2901/2/2901_FEBS%23XCJ.pdf URI http://hdl.handle.net/10795/2901 LOMv1.0creator 2016-04-25T12:46:58Z LOMv1.0validator 2016-04-25T12:46:58Z LOMv1.0 gre no no Copyright EYD-EPEDBM (Operational Programme "Education and Lifelong Learning")